LifeStance Health Debt to Equity Ratio 2020-2025 | LFST
Current and historical debt to equity ratio values for LifeStance Health (LFST) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. LifeStance Health debt/equity for the three months ending December 31, 2025 was 0.17.
| LifeStance Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-12-31 | $0.68B | $1.52B | 0.45 |
| 2025-09-30 | $0.66B | $1.49B | 0.44 |
| 2025-06-30 | $0.67B | $1.47B | 0.46 |
| 2025-03-31 | $0.65B | $1.46B | 0.44 |
| 2024-12-31 | $0.67B | $1.45B | 0.47 |
| 2024-09-30 | $0.67B | $1.44B | 0.47 |
| 2024-06-30 | $0.69B | $1.43B | 0.48 |
| 2024-03-31 | $0.68B | $1.43B | 0.47 |
| 2023-12-31 | $0.68B | $1.43B | 0.48 |
| 2023-09-30 | $0.72B | $1.46B | 0.50 |
| 2023-06-30 | $0.68B | $1.50B | 0.45 |
| 2023-03-31 | $0.65B | $1.51B | 0.43 |
| 2022-12-31 | $0.66B | $1.52B | 0.43 |
| 2022-09-30 | $0.45B | $1.53B | 0.29 |
| 2022-06-30 | $0.44B | $1.53B | 0.29 |
| 2022-03-31 | $0.42B | $1.54B | 0.27 |
| 2021-12-31 | $0.38B | $1.55B | 0.25 |
| 2021-09-30 | $0.37B | $1.55B | 0.24 |
| 2021-06-30 | $0.37B | $1.55B | 0.24 |
| 2021-03-31 | $0.65B | $0.95B | 0.68 |
| 2020-12-31 | $0.57B | $1.00B | 0.57 |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2020-06-30 | $0.00B | $0.00B | 0.00 |
| 2020-03-31 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.45B | $-0.17B | -2.69 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $2.495B | $1.424B |
| LifeStance Health Group Inc. is provider of virtual and in-person outpatient mental health care for children, adolescents and adults of mental health conditions. LifeStance Health Group Inc. is based in SCOTTSDALE, Ariz. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |